Mapletree Pan Asia Commercial Trust
SGX:N2IU
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.13
1.48
|
| Price Target |
|
We'll email you a reminder when the closing price reaches .
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of N2IU.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Simon Property Group Inc
NYSE:SPG
|
|
| US |
|
Realty Income Corp
NYSE:O
|
|
| SG |
|
CapitaLand Integrated Commercial Trust
SGX:C38U
|
|
| AU |
|
Scentre Group
ASX:SCG
|
|
| US |
|
Kimco Realty Corp
NYSE:KIM
|
|
| US |
|
Regency Centers Corp
NASDAQ:REG
|
|
| HK |
|
Link Real Estate Investment Trust
HKEX:823
|
|
| FR |
|
Klepierre SA
PAR:LI
|
|
| US |
|
Federal Realty Investment Trust
NYSE:FRT
|
|
| FR |
|
Unibail-Rodamco-Westfield SE
AEX:URW
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Mapletree Pan Asia Commercial Trust
Balance Sheet Decomposition
Mapletree Pan Asia Commercial Trust
| Current Assets | 202.9m |
| Cash & Short-Term Investments | 225.6m |
| Receivables | 21.7m |
| Other Current Assets | -44.4m |
| Non-Current Assets | 15.9B |
| Long-Term Investments | 15.8B |
| PP&E | 1.8m |
| Other Non-Current Assets | 97.3m |
| Current Liabilities | 684.5m |
| Accounts Payable | 242.6m |
| Accrued Liabilities | 98m |
| Other Current Liabilities | 344m |
| Non-Current Liabilities | 5.8B |
| Long-Term Debt | 5.6B |
| Other Non-Current Liabilities | 293.3m |
Free Cash Flow Analysis
Mapletree Pan Asia Commercial Trust
| SGD | |
| Free Cash Flow | SGD |
Earnings Waterfall
Mapletree Pan Asia Commercial Trust
|
Revenue
|
883.7m
SGD
|
|
Cost of Revenue
|
-263.9m
SGD
|
|
Gross Profit
|
619.8m
SGD
|
|
Operating Expenses
|
-7.7m
SGD
|
|
Operating Income
|
612.1m
SGD
|
|
Other Expenses
|
77.2m
SGD
|
|
Net Income
|
689.3m
SGD
|
N2IU Profitability Score
Profitability Due Diligence
Mapletree Pan Asia Commercial Trust's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Mapletree Pan Asia Commercial Trust's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
N2IU Solvency Score
Solvency Due Diligence
Mapletree Pan Asia Commercial Trust's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Mapletree Pan Asia Commercial Trust's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
N2IU Price Targets Summary
Mapletree Pan Asia Commercial Trust
According to Wall Street analysts, the average 1-year price target for
N2IU
is 1.57
with a low forecast of 1.16 and a high forecast of 1.93 .
Dividends
Current shareholder yield for
N2IU is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?